Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinomaNan Zhang, Haitao Zhao, Yanyu Wang et al.|Biomarker Research|2024Cited by 82
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Haitao Zhao, Bowen Chen et al.|Hepatology International|2023Cited by 60
Nerve growth factor from Chinese cobra venom stimulates chondrogenic differentiation of mesenchymal stem cellsZhenhui Lu, Jinmin Zhao|Cell Death and Disease|2017Cited by 56
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinomaXu Yang, Haitao Zhao, Baofeng Lian et al.|BMC Medicine|2024Cited by 43